IGEA PHARMA
IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. IGEA commercializes an Alzheimer's prevention set (which includes 'Alz1', an at-home lab test kit to measure non-bound copper in the blood and a natural dietary supplement branded 'Alz1 Tab' designed to reduce blood heavy metals content) and expects to integrate the non-bound copper detection-based pipeline with a diabetes type II prevention set in 2021.
IGEA PHARMA
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Hoofddorp, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.igeapharma.nl
Status:
Active
Contact:
+31 23 568 94 94
Email Addresses:
[email protected]
Total Funding:
2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Google Maps
Similar Organizations
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Stock Details
Investors List
Negma Group
Negma Group investment in Post-IPO Debt - Igea Pharma
Official Site Inspections
http://www.igeapharma.nl
- Host name: 114.162.214.35.bc.googleusercontent.com
- IP address: 35.214.162.114
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
